BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bridges JFP, Paly VF, Barker E, Kervitsky D. Identifying the Benefits and Risks of Emerging Treatments for Idiopathic Pulmonary Fibrosis: A Qualitative Study. Patient 2015;8:85-92. [DOI: 10.1007/s40271-014-0081-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Kimman ML, Rotteveel AH, Wijsenbeek M, Mostard R, Tak NC, van Jaarsveld X, Storm M, Wijnsma KL, Gelens M, van de Kar NCAJ, Wetzels J, Dirksen CD. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire). Patient 2017;10:629-42. [PMID: 28357591 DOI: 10.1007/s40271-017-0234-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
2 Janssens R, Russo S, van Overbeeke E, Whichello C, Harding S, Kübler J, Juhaeri J, Bywall KS, Comanescu A, Hueber A, Englbrecht M, Nikolenko N, Pravettoni G, Simoens S, Stevens H, Hermann R, Levitan B, Cleemput I, de Bekker-Grob E, Veldwijk J, Huys I. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA. Patient 2019;12:513-26. [PMID: 31222436 DOI: 10.1007/s40271-019-00367-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
3 Moor CC, Wijsenbeek MS, Balestro E, Biondini D, Bondue B, Cottin V, Flewett R, Galvin L, Jones S, Molina-Molina M, Planas-Cerezales L, Prasse A, Prosch H, Russell AM, Viegas M, Wanke G, Wuyts W, Kreuter M, Bonella F. Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey. ERJ Open Res 2019;5:00124-2019. [PMID: 31649949 DOI: 10.1183/23120541.00124-2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
4 Bicket AK, Le JT, Yorkgitis C, Li T. Priorities and Treatment Preferences among Surgery-Naive Patients with Moderate to Severe Open-Angle Glaucoma. Ophthalmol Glaucoma 2020;3:377-83. [PMID: 32768363 DOI: 10.1016/j.ogla.2020.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Janssens R, Huys I, van Overbeeke E, Whichello C, Harding S, Kübler J, Juhaeri J, Ciaglia A, Simoens S, Stevens H, Smith M, Levitan B, Cleemput I, de Bekker-Grob E, Veldwijk J. Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Med Inform Decis Mak 2019;19:189. [PMID: 31585538 DOI: 10.1186/s12911-019-0875-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
6 Lee JY, Tikellis G, Corte TJ, Goh NS, Keir GJ, Spencer L, Sandford D, Khor YH, Glaspole I, Price J, Hey-cunningham AJ, Maloney J, Teoh AK, Watson AL, Holland AE. The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review. Eur Respir Rev 2020;29:190125. [DOI: 10.1183/16000617.0125-2019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
7 Pitts PJ. The Patient Voice: At the Intersection of a US Regulatory Revolution. Patient 2016;9:373-7. [PMID: 27581685 DOI: 10.1007/s40271-016-0192-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Tikellis G, Tong A, Lee JYT, Corte TJ, Hey-Cunningham AJ, Bartlett M, Crawford T, Glaspole I, Price J, Maloney J, Holland AE. Top 10 research priorities for people living with pulmonary fibrosis, their caregivers, healthcare professionals and researchers. Thorax 2021;76:575-81. [PMID: 33277429 DOI: 10.1136/thoraxjnl-2020-215731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hollin IL, Dimmock AE, Bridges JF, Danoff SK, Bascom R. Collecting patient preference information using a Clinical Data Research Network: demonstrating feasibility with idiopathic pulmonary fibrosis. Patient Prefer Adherence 2019;13:795-804. [PMID: 31190761 DOI: 10.2147/PPA.S201632] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 van Manen MJ, Kreuter M, van den Blink B, Oltmanns U, Palmowski K, Brunnemer E, Hummler S, Tak NC, van den Toorn L, Miedema J, Hoogsteden HC, Wijsenbeek MS. What patients with pulmonary fibrosis and their partners think: a live, educative survey in the Netherlands and Germany. ERJ Open Res 2017;3:00065-2016. [PMID: 28229083 DOI: 10.1183/23120541.00065-2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
11 Camelo Castillo W, Heath N, Kim J, Yang K, Ritchey ME, dosReis S, Santanello N, West SL. Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations. Pharmacoepidemiol Drug Saf 2019;28:766-76. [DOI: 10.1002/pds.4786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Johannson KA, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris J, Udwadia Z, Wells A, Wijsenbeek M. Palliative care in interstitial lung disease: living well. Lancet Respir Med 2017;5:968-80. [PMID: 29033267 DOI: 10.1016/S2213-2600(17)30383-1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 34] [Article Influence: 18.4] [Reference Citation Analysis]
13 Janssens R, van Overbeeke E, Verswijvel L, Meeusen L, Coenegrachts C, Pauwels K, Dooms M, Stevens H, Simoens S, Huys I. Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice. Front Med (Lausanne) 2018;5:285. [PMID: 30364285 DOI: 10.3389/fmed.2018.00285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
14 Janssen EM, Segal JB, Bridges JFP. A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes. Patient 2016;9:465-79. [DOI: 10.1007/s40271-016-0170-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
15 Facey K, Hansen HP. The imperative for patient-centred research to develop better quality services in rare diseases. Patient 2015;8:1-3. [PMID: 25616560 DOI: 10.1007/s40271-015-0113-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Janssen EM, Bridges JFP. Art and Science of Instrument Development for Stated-Preference Methods. Patient 2017;10:377-9. [DOI: 10.1007/s40271-017-0261-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]